secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biotech Acquisition Co (—)
CIK:        0001825413
Form:       8-K
Filed at:   2023-01-11T23:59:59+00:00
Accession:  0001213900-23-002153
Event type: regulatory
Sentiment:  negative
Materiality: 0.35
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biotech Acquisition receives Nasdaq deficiency notice for missed annual meeting
-------------------------------------------------------------------------------

- Received Nasdaq notice on Jan 9, 2023 for failing to hold annual meeting for FY ended Dec 31, 2021.
- Company must submit a plan to regain compliance by Feb 23, 2023.
- If plan accepted, Nasdaq may grant extension until June 29, 2023 to comply.
- Deficiency notice has no immediate effect on listing or trading.
- Company intends to submit a compliance plan within required timeframe.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1825413/000121390023002153/0001213900-23-002153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1825413/000121390023002153/ea171538-8k_biotechacq.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-002153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer